|1.||Watanabe, W: 1 article (01/2001)|
|2.||Konno, K: 1 article (01/2001)|
|3.||Yokota, T: 1 article (01/2001)|
|4.||Sudo, K: 1 article (01/2001)|
|5.||Shigeta, S: 1 article (01/2001)|
04/01/1999 - "Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice."
01/01/2001 - "A time-dependent drug addition experiment indicated that the antiviral activity occurs in the late stage of the RSV replication cycle, since this compound completely inhibited syncytium formation even when added up to 16 hr after the infection of cell monolayers at an MOI of 3. RD3-0028 had no direct virucidal effect on RSV. "
04/01/1999 - "We used a mouse model of RSV infection to determine the in vivo effect of RD3-0028. "